Abstract Purpose: To evaluate the role of proton MR spectroscopy in differentiating low grade glioma and glioblastoma multiform.Materials and Methods: This work included 50 patients with different brain tumors attended radiology department with their age ranged from 35 months - 80 years. Results: Validity measures of MRS in detecting grading of brain gliomas versus histopathological findings were sensitivity 88%, specificity 81%, PPV 80%, NPV 90% and total accuracy 85%. Conclusion: When paired with cMRI, MR Spectroscopy is regarded as a crucial clinical diagnostic tool that improves glioma grading accuracy.
Osama, A., & El Sheikh, R. (2021). Proton MR Spectroscopy in Differenating Low Grade Glioma and Glioblastoma Multiform.. Minia Journal of Medical Research, 32(1), 116-121. doi: 10.21608/mjmr.2021.292204
MLA
Ayman Osama; Rehab El Sheikh. "Proton MR Spectroscopy in Differenating Low Grade Glioma and Glioblastoma Multiform.". Minia Journal of Medical Research, 32, 1, 2021, 116-121. doi: 10.21608/mjmr.2021.292204
HARVARD
Osama, A., El Sheikh, R. (2021). 'Proton MR Spectroscopy in Differenating Low Grade Glioma and Glioblastoma Multiform.', Minia Journal of Medical Research, 32(1), pp. 116-121. doi: 10.21608/mjmr.2021.292204
VANCOUVER
Osama, A., El Sheikh, R. Proton MR Spectroscopy in Differenating Low Grade Glioma and Glioblastoma Multiform.. Minia Journal of Medical Research, 2021; 32(1): 116-121. doi: 10.21608/mjmr.2021.292204